Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers (clinicaltrials.gov) - Sep 25, 2026 - P3 | N=2300 | Not yet recruiting | Sponsor: Bristol-Myers Squibb | Initiation date: Sep 2026 ➔ Dec 2026
Trial initiation date • Immunology • Inflammatory Arthritis • Lupus • Pediatrics • Systemic Lupus Erythematosus
|